Retinalamin efficiency and methods of its use in the treatment of diabetic retinopathy
DOI:
https://doi.org/10.11603/2414-4533.2015.2.5222Abstract
An intensive scientific search is in recent year conductedsent to cognition of different links of difficult pathogenesis of diabetic retinopathys (DR), and methods of treatment of the last. Work is sanctified to the study of efficiency of application of retinalamine in treatment of patients from DR. An inspection and treatment of patients was conducted with preproliferative and proliferative DR, in two clinical groups. In the first group retinalamine was entered a group to the patients in a dose 5.0 mg every day during 10 days, in second group – 1.0 ml of retinalamine were entered to patients in dose of 5.0 mg singly in subconjunctiveal space. As a result there was an improvement of indexes of electrophysiological parameters in both groups of treatment, lability of optic nerve considerably more distinctly in ІІ research group. On a background treatment with retinalamine for the patients of both groups the reduction was marked by decreasement of retinas, an especially macular oedema diminished in ІІ group of patients when injected drug in subconjunctiveal space. Positive trends were determined : visual acuity at 0.05–0.2 % and functional activity of the retina in 68 % of patients demonstrate efficacy, especially when it is injected into the subconjunctiveal space of the eye.
References
Дедов И. И. Сахарный диабет: ретинопатия, нефропатія / И. И. Дедов, М. В. Шестакова, Т. М. Миленькая “Библиотека практикующего врача”. – М. : Медицина, 2001. – 175 с.
Максимов И. Б. Применение препарата ретиналамин в офтальмологи : пособие для врачей / И. Б. Максимов, В. В. Нероев, В. Н. Алексеев. – СПб., 2003. – 20 с.
Максимов И. Б. Ретиналамин в комплексном лечении инволюционных центральних дистрофий / И. Б. Максимов, Л. К. Мошетова, С. А. Савостьянова. – СПб., 2006. – 96 с.
Шестакова М. В. Блокада ренин-ангиотензиновой системы в профилактике и лечении диабетической ретинопатии: результаты исследования DIRECT [Режим доступа] / М. В. Шестакова, М. Ш. Шамхалова // Сonsilium Medicum. – 2008. – Т. 10, № 9 – Режим доступа : (http://www.consilium-medicum.com/magazines/cm/medicum/article/16023)
Antonetti D. A. Diabetic Retinopathy / D. A. Antonetti, R. Klein, T. W. Gardner // Engl. J. Med. – 2012. – 366. – Р. 1227–1239.
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2 / M. Michaelides, A. Kaines, R. D. Hamilton [et al.] // Ophthalmology. – 2010. – 117(6). – P. 1078–1086.
A Role for Omega-3 Polyunsaturated Fatty Acid Supplements in Diabetic Neuropathy / P. Yee, A. E. Weymouth, E. L. Fletcher, A. J. Vingrys // Inves. Ophthalmol. Vis. Sci. – 2010. – Vol. 51(3). – Р. 1755–1764.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
